Othman A. Al-Shabanah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Othman A. Al-Shabanah has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
A.M. Al-Bekairi
1 shared publicationA.M. Osman
1 shared publicationAbdulaziz M. Aleisa
Department of Pharmacology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, 11451, Saudi Arabia
1 shared publication- Abdullah B. Juwair
College of Medicine, Al Imam Mohammad Ibn Saud Islamic University (IMSIU). Riyadh (Saudi Arabia).
1 shared publication - Abdullah Tawfih Abdullah Khoja
Public Health and Family Medicine Departments, College of Medicine, Al-Imam Muhammad ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia
1 shared publication - Ali Azeez Al-Jumaili
Department of Clinical Pharmacy, College of Pharmacy, University of Baghdad, Baghdad, Iraq
1 shared publication
Latest Publications
- Open Access
- 30 September 2018
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 16 (3) , 1223
Measuring the health literacy level of Arabic speaking population in Saudi Arabia using translated health literacy instruments
Pharmacy Practice is a free full-text journal with a scope on the practice of pharmacy. Pharmacy Practice covers pharmaceutical care, social pharmacy, pharmacy education, process and outcome research, health promotion and education, health informatics, pharmacoepidemiology
- 30 September 2018
- Published by JCFCorp SG PTE LTD in Pharmacy Practice
- Vol. 16 (3) , 1223
Open AccessMeasuring the health literacy level of Arabic speaking population in Saudi Arabia using translated health literacy instruments
Pharmacy Practice is a free full-text journal with a scope on the practice of pharmacy. Pharmacy Practice covers pharmaceutical care, social pharmacy, pharmacy education, process and outcome research, health promotion and education, health informatics, pharmacoepidemiology
- 1 August 2010
- Published by Elsevier in European Journal of Pharmacology
- Vol. 640 (1-3) , 143-149
Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model
- 1 August 2010
- Published by Elsevier in European Journal of Pharmacology
- Vol. 640 (1-3) , 143-149
Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model
- 1 May 2006
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 41 (2) , 571-575
Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus
- 1 May 2006
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 41 (2) , 571-575
Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus
- 1 January 1994
- Published by S. Karger AG in Chemotherapy
- Vol. 40 (3) , 188-194
Enhancement of Doxorubicin-Induced Cytotoxicity by Hyperthermia in Ehrlich Ascites Cells
Hyperthermia (HPT) at 43 °C for 30 min increased the cytotoxic activity of doxorubicin against the growth of Ehrlich ascites carcinoma cells. There was more delay in tumor growth with 89% inhibition in the tumor volume and 90% increase in the survival of the tumor-bearing animals compared to control group. Combination of HPT with doxorubicin showed a more pronounced inhibitory effect on tumor content of DNA, RNA, protein, cholesterol, total lipid and acid phosphatase activity. HPT did not significantly affect the doxorubicin uptake into tumor cells, but it has some inhibitory effect on some vital components. Along with other results, our data suggest the benefit of using HPT to enhance the cytotoxic activity of doxorubicin with a consequent reduction of doxorubicin dose and hence a decrease of its serious side effects.
- 1 January 1994
- Published by S. Karger AG in Chemotherapy
- Vol. 40 (3) , 188-194
Enhancement of Doxorubicin-Induced Cytotoxicity by Hyperthermia in Ehrlich Ascites Cells
Hyperthermia (HPT) at 43 °C for 30 min increased the cytotoxic activity of doxorubicin against the growth of Ehrlich ascites carcinoma cells. There was more delay in tumor growth with 89% inhibition in the tumor volume and 90% increase in the survival of the tumor-bearing animals compared to control group. Combination of HPT with doxorubicin showed a more pronounced inhibitory effect on tumor content of DNA, RNA, protein, cholesterol, total lipid and acid phosphatase activity. HPT did not significantly affect the doxorubicin uptake into tumor cells, but it has some inhibitory effect on some vital components. Along with other results, our data suggest the benefit of using HPT to enhance the cytotoxic activity of doxorubicin with a consequent reduction of doxorubicin dose and hence a decrease of its serious side effects.